Independent Equity Research

Independent research on Europe's uncovered small caps

Long-form, primary-source research on listed small caps in Switzerland, Italy, Austria and Germany — companies no one else covers.

Equity Research · Euronext Growth Milan

Cyberoo: The Deadlines Are the Demand

A fiscal year stretched to fifteen months makes every headline growth rate incomparable, and the extra quarter added almost nothing: on the company's own like-for-like figures, the January–March 2026 stub contributed roughly €1.7m of cybersecurity revenue against a 2025 monthly average of about the same. Underneath, monthly EBITDA fell by roughly 30% while margin dropped eleven points. The genuine news is working capital — receivables from the largest shareholder fell from €11.5m to €2.6m — but €5.3m of that left by offset rather than cash, and an unconsolidated leasing subsidiary with a €15m facility now sits beside the group's receivables machinery. No rating.

IT · CYB · 4 July 2026 · 11 min read
Equity Research · Euronext Growth Milan

TECMA Solutions: An Italian Proptech Sold to the AI Woodchipper

TECMA Solutions is a €17m Italian proptech that builds software, configurators and digital marketing infrastructure for residential real-estate developers. It lost €1.06m on €12.4m of revenue in FY2025, down 11% on the year, has accumulated losses larger than its equity, and trades on EGM — the segment most exposed to small-cap flight. None of those facts is the story. The story is that TECMA is the natural counter-example to our own SMG thesis: a company that sells capability to real-estate developers, not liquidity between them, and is therefore the kind of name where the AI-disintermediation argument actually has purchase. We initiate coverage at a Marketweight. The market is roughly right on the company; we want to own it only on a substantial derating or a tangible proof that its international and recurring-revenue shift survives the cycle.

IT · TCM · 3 July 2026 · 26 min read
The Thesis

Where attention is scarce, mispricing is not.

No coverage, no scrutiny

Below €500m of market value, sell-side coverage thins; below €150m it has all but vanished. Prices there are set by fund flows, family holdings and habit — rarely by anyone who has read the accounts.

A few names, fully understood

We would rather know a handful of businesses completely than skim hundreds. An initiation is months of filings, registries, site visits and interviews — and most companies we examine, we decline.

Paid to wait

We look for cash-generative businesses priced to hold up even if nothing goes right. The safety is in what we pay; a margin recovery, a re-rating or first coverage is upside we haven’t paid for.